Adaptive Biotechnologies

In News

Adaptive Biotechnologies (ADPT): Valuation Check After ASH clonoSEQ Data Spotlight and Q3 Earnings Beat - simplywall.st

simplywall.st - Dec 08, 2025

Adaptive Biotechnologies CEO Chad M Robins Sells $3M in Company Shares - StocksToTrade

StocksToTrade - Dec 07, 2025

Adaptive Biotechnologies’ Earnings Call Highlights Growth and Challenges - MSN

MSN - Dec 08, 2025

Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at ASH Meeting - GuruFocus

GuruFocus - Dec 07, 2025

Adaptive Biotechnologies Stock Declines After Insider Sale - timothysykes.com

timothysykes.com - Dec 07, 2025

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting - GlobeNewswire

GlobeNewswire - Dec 06, 2025

Adaptive Biotechnologies announces growing interventional use of clonoSEQ test - TipRanks

TipRanks - Dec 07, 2025

Assessing Adaptive Biotechnologies (ADPT) Valuation After a 179% One-Year Rebound and Recent Pullback - Yahoo Finance

Yahoo Finance - Dec 04, 2025

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock - Investing.com

Investing.com - Dec 05, 2025

Adaptive Biotechnologies (Nasdaq: ADPT) shows clonoSEQ MRD guiding blood cancer care at ASH 2025 - Stock Titan

Stock Titan - Dec 06, 2025

Can Adaptive Biotechnologies Stock Recover If Markets Fall? - Trefis

Trefis - Dec 06, 2025

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga

Benzinga - Dec 05, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment